Objective To provide evidence to support updated guidelines for the management of
pregnant women with hereditary thrombophilia in order to reduce the risk of a first venous …

Factor V Leiden is a genetic disorder characterized by a poor anticoagulant response to
activated Protein C and an increased risk for venous thromboembolism. Deep venous …

Growing evidence suggests that thrombophilia is associated with venous thromboembolism
(VTE) and adverse pregnancy outcomes. However, methodological limitations have made it …

Background: Venous thrombosis is one of the leading causes of maternal morbidity and
mortality. Objective: In the MEGA study, we evaluated pregnancy and the postpartum period …

The annual incidence of venous thrombosis, one of the leading causes of mortality and
morbidity, increases from 1 per 100,000 during childhood to 1 per 100 in old age. 1 In this …

Context: It has been suggested that elevated total plasma homocysteine levels are
associated with the risk of venous thrombosis. Objective: To assess the relationship of …

Pulmonary embolism (PE) is the leading cause of maternal mortality in the developed world.
Mortality from PE in pregnancy might be related to challenges in targeting the right …

This chapter about the use of antithrombotic agents during pregnancy is part of the Seventh
ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based …

Objective: We sought to estimate the frequency of pregnancy-related thromboembolic events
among carriers of the factor V Leiden (FVL) mutation without a personal history of …

The third edition of the book, Practical Guide to High-Risk Pregnancy and Delivery, has
been completely revised to present more up-to-date approach to the field. Several changes …